Gustafsson O, Krishna S, Borate S, Ghaeidamini M, Liang X, Saher O, et al. Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types. J Control Release. 2025;386:114038 pubmed publisher

Le T, Chu V, Lino A, Schrezenmeier E, Kressler C, Hamo D, et al. Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators. Mol Ther Nucleic Acids. 2022;30:621-632 pubmed publisher

Chimienti R, Baccega T, Torchio S, Manenti F, Pellegrini S, Cospito A, et al. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement. Cell Rep. 2022;40:111423 pubmed publisher

Haideri T, Howells A, Jiang Y, Yang J, Bao X, Lian X. Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells. Cell Rep Methods. 2022;2:100290 pubmed publisher

Kishton R, Patel S, Decker A, Vodnala S, Cam M, Yamamoto T, et al. Cancer genes disfavoring T cell immunity identified via integrated systems approach. Cell Rep. 2022;40:111153 pubmed publisher

Sim M, Stotz Z, Lu J, Brennan P, Long E, Sun P. T cells discriminate between groups C1 and C2 HLA-C. elife. 2022;11: pubmed publisher

Li Y, Zhou Y, Kim Y, Zhu Y, Ma F, Yu J, et al. Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. Cell Rep Med. 2021;2:100449 pubmed publisher

Song S, Manook M, Kwun J, Jackson A, Knechtle S, Kelsoe G. Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells. Front Immunol. 2021;12:705140 pubmed publisher

Hamilton J, Tsuchida C, Nguyen D, Shy B, McGarrigle E, Sandoval Espinoza C, et al. Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 2021;35:109207 pubmed publisher

DeWeirdt P, Sanson K, Sangree A, Hegde M, Hanna R, Feeley M, et al. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat Biotechnol. 2020;: pubmed publisher

Zhuang X, Veltri D, Long E. Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ. Front Immunol. 2019;10:2879 pubmed publisher

Xu X, Gao D, Wang P, Chen J, Ruan J, Xu J, et al. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation. Sci Rep. 2018;8:11649 pubmed publisher

Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher

Chung H, Calis J, Wu X, Sun T, Yu Y, Sarbanes S, et al. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell. 2018;172:811-824.e14 pubmed publisher

Gondim M, Wiltzer Bach L, Maurer B, Banning C, Argañaraz E, Schindler M. AP-2 Is the Crucial Clathrin Adaptor Protein for CD4 Downmodulation by HIV-1 Nef in Infected Primary CD4+ T Cells. J Virol. 2015;89:12518-24 pubmed publisher